Intracellular localization of the cyclin-dependent kinase inhibitor p21CDKN1A-GFP fusion protein during cell cycle arrest

被引:0
|
作者
Ornella Cazzalini
Paola Perucca
Federica Valsecchi
Lucia A. Stivala
Livia Bianchi
Vanio Vannini
Ennio Prosperi
机构
[1] Istituto di Genetica Molecolare del CNR,sez. Istochimica e Citometria
[2] Università di Pavia,Dipartimento di Medicina Sperimentale, sez. Patologia generale “C. Golgi”
来源
Histochemistry and Cell Biology | 2004年 / 121卷
关键词
p21; Cell cycle arrest; Green fluorescent protein; Cyclins; Nucleolus;
D O I
暂无
中图分类号
学科分类号
摘要
The cyclin-dependent kinase (CDK) inhibitor p21CDKN1A is known to induce cell cycle arrest by inhibiting CDK activity and by interfering with DNA replication through binding to proliferating cell nuclear antigen. Although the molecular mechanisms have been elucidated, the temporal dynamics, as well as the intracellular sites of the activity of p21 bound to cyclin/CDK complexes during cell cycle arrest, have not been fully investigated. In this study we have induced the expression of p21CDKN1A fused to green fluorescent protein (GFP) in HeLa cells, in order to visualize the intracellular localization of the inhibitor during the cell cycle arrest. We show that p21-GFP is preferentially expressed in association with cyclin E in cells arrested in G1 phase, and with cyclin A more than with cyclin B1 in cells arrested in the G2/M compartment. In addition, we show for the first time that p21-GFP colocalizes with cyclin E in the nucleolus of HeLa cells during the G1 phase arrest.
引用
收藏
页码:377 / 381
页数:4
相关论文
共 50 条
  • [21] Expression of cyclin-dependent kinase inhibitor p21 in human liver
    Crary, GS
    Albrecht, JH
    HEPATOLOGY, 1998, 28 (03) : 738 - 743
  • [22] Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein
    Nakanishi, M
    Kaneko, Y
    Matsushime, H
    Ikeda, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 263 (01) : 35 - 40
  • [23] The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest
    Nishi, K
    Schnier, JB
    Bradbury, EM
    EXPERIMENTAL CELL RESEARCH, 1998, 243 (02) : 222 - 231
  • [24] Regulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1 by protein kinase Cδ-mediated phosphorylation
    You-Take Oh
    Kwang Hoon Chun
    Byoung Duck Park
    Joon-Seok Choi
    Seung Ki Lee
    Apoptosis, 2007, 12 : 1339 - 1347
  • [25] Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy
    Okamoto, K
    Kato, S
    Arima, N
    Fujii, T
    Morimatsu, M
    Imaizumi, T
    HYPERTENSION RESEARCH, 2004, 27 (04) : 283 - 291
  • [26] Regulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1 by protein kinase Cδ-mediated phosphorylation
    Oh, You-Take
    Chun, Kwang Hoon
    Park, Byoung Duck
    Choi, Joon-Seok
    Lee, Seung Ki
    APOPTOSIS, 2007, 12 (07) : 1339 - 1347
  • [27] Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21(WAF1/CIP1) mediated by STAT1
    Chin, YE
    Kitagawa, M
    Su, WCS
    You, ZH
    Iwamoto, Y
    Fu, XY
    SCIENCE, 1996, 272 (5262) : 719 - 722
  • [28] The mitogen-activated protein kinase cascade promotes myoblast cell survival by stabilizing the cyclin-dependent kinase inhibitor, p21WAF1 protein
    Ostrovsky, O
    Bengal, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (23) : 21221 - 21231
  • [29] Inhibition of smooth muscle cell migration by the p21 cyclin-dependent kinase inhibitor (Cip1)
    Fukui, R
    Shibata, N
    Kohbayashi, E
    Amakawa, M
    Furutama, D
    Hoshiga, M
    Negoro, N
    Nakakouji, T
    Ii, M
    Ishihara, T
    Ohsawa, N
    ATHEROSCLEROSIS, 1997, 132 (01) : 53 - 59
  • [30] Cyclin-dependent kinase inhibitor p20 controls circadian cell-cycle timing
    Laranjeiro, Ricardo
    Tamai, T. Katherine
    Peyric, Elodie
    Krusche, Peter
    Ott, Sascha
    Whitmore, David
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (17) : 6835 - 6840